World-Leading Scientists Set to Explore Human and Animal Consciousness at the Francis Crick Memorial Conference, Cambridge UK, July 7 2012

CAMBRIDGE, UK--(BUSINESS WIRE)--Brain researchers from all over the world will gather at the University of Cambridge on July 7th, 2012 for the first international scientific conference focusing exclusively on consciousness in both human and non-human animals. This landmark conference is named in honor of the late Sir Francis Crick, who co-discovered the structure of DNA while in the Cavendish laboratory at the University of Cambridge, and ardently investigated the mystery of consciousness for the remainder of his career while at the Salk Institute for Biological Studies in the USA. The event will open with a lecture by longtime Crick collaborator, Caltech’s Christof Koch, and conclude with a presentation of a study co-authored by NeuroVigil’s Philip Low and Cambridge’s Stephen Hawking. The meeting will also highlight cutting-edge non-invasive techniques for studying consciousness in rodents, flies, octopuses, birds, dolphins, elephants, non-human primates and humans, including comatose patients. Quantitative results from behavioral, neuroethological and anatomical studies performed by Donald Pfaff, Bruno van Swinderen, David Edelman, Irene Pepperberg, Harvey Karten, Diana Reiss, Ryan Remedios, Nikos Logothetis, Christoph Kayser, Franz Vollenweider, Naotsugu Tsuchiya, Melanie Boly and Steven Laureys will be presented. The notion that only humans possess consciousness is expected to be vigorously challenged. The result of this data-driven debate may well transform our understanding of consciousness, reveal commonalities across species and prompt a reassessment of human-animal interactions. For more information on this groundbreaking conference, please visit: http://www.neurovigil.com/fcmc/

ABOUT NEUROVIGIL

NeuroVigil, Inc. is dedicated to the betterment of the human condition by merging non-invasive wireless brain recording technology with advanced computational analysis techniques applied exclusively on human data. The award-winning company has developed proprietary technology which leverages the dynamic oscillations produced across the sleep/wake cycle in order to systematically scan the human brain for signs of pathologic activity years in advance of cognitive or behavioral symptoms. For more information: http://www.neurovigil.com